South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

Summary

GlobalData, the industry analysis specialist, has released its latest report, “South Korea Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The South Korean pharmaceutical market increased from $20.3B in 2011 to $26.4B in 2018, at a Compound Annual Growth Rate (CAGR) of 3.8%. It is forecast to reach $34.3B by 2025. The South Korean biopharmaceutical market was $2B in 2013 that increased at a YoY (Year on Year) growth rate of 21.95% to reach $2.5B in 2018. The South Korean medical device market was valued at $6.9B in 2015, which increased to $8.3B in 2019. The market is expected to grow at a CAGR of 4.8% from $8.7B in 2020 to $9.6B in 2022. South Korea has free trade agreements with the US, EU and India. These agreements help in eliminating trade barriers and attracting foreign investment.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in South Korea, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Merck, Novartis, AstraZeneca, Daewoong Pharmaceutical, and Celltrion
- Profiles and SWOT analyses of the major players in the medical device market: GE Healthcare, Stryker, Boston Scientific, and Alcon.
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the South Korean healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving South Korea’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact South Korea’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership